Cellectis S.A. (CLLS) vs Fate Therapeutics, Inc. (FATE)
Detailed comparison between Cellectis S.A., Fate Therapeutics, Inc..Total Return (%)
Cellectis S.A. (CLLS)Fate Therapeutics, Inc. (FATE)
Which stock do you think will perform better?
Cellectis S.A.
CLLS
Fate Therapeutics, Inc.
FATE
| Metric | Cellectis S.A. (CLLS) | Fate Therapeutics, Inc. (FATE) |
|---|---|---|
| Current Price | $1.45 | $1.11 |
| Change | 0.02 (1.40%) | 0.06 (5.71%) |
| Market Cap | $0.20B | $0.13B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -1.91 | -0.66 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $3.38 | $5.92 |
| 52-Week Low | $1.10 | $0.66 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-0.41 | $-1.64 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| CLLS | 10.69% | -7.05% | -44.66% | -88.55% | -95.56% | -95.54% |
| FATE | 18.09% | -17.16% | -75.55% | -96.23% | -81.95% | -83.43% |